Role of albiglutide in the treatment of type 2 diabetes. Issue 6 (June 2016)
- Record Type:
- Journal Article
- Title:
- Role of albiglutide in the treatment of type 2 diabetes. Issue 6 (June 2016)
- Main Title:
- Role of albiglutide in the treatment of type 2 diabetes
- Authors:
- Chaplin, Steve
- Abstract:
- Abstract : Albiglutide (Eperzan) is a GLP‐1 agonist licensed for the treatment of type 2 diabetes in adults to improve glycaemic control. This article discusses its indications, efficacy and adverse effects.
- Is Part Of:
- Prescriber. Volume 27:Issue 6(2016:Jun.)
- Journal:
- Prescriber
- Issue:
- Volume 27:Issue 6(2016:Jun.)
- Issue Display:
- Volume 27, Issue 6 (2016)
- Year:
- 2016
- Volume:
- 27
- Issue:
- 6
- Issue Sort Value:
- 2016-0027-0006-0000
- Page Start:
- 34
- Page End:
- 35
- Publication Date:
- 2016-06
- Subjects:
- Chemotherapy -- Periodicals
Drugs -- Prescribing -- Periodicals
615.1 - Journal URLs:
- http://www.prescriber.co.uk/view/0/index.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/psb.1471 ↗
- Languages:
- English
- ISSNs:
- 0959-6682
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6609.700100
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 39.xml